Zobrazeno 1 - 10
of 35
pro vyhledávání: '"William R. Friedenberg"'
Autor:
William L. White, Thomas M. Habermann, Debra A. Welker, Thomas R. Fitch, William R. Friedenberg, Paul J. Kurtin, Haji Chalchal, Susan Geyer, Thomas E. Witzig, Allen M. Vukov, Patrick J. Flynn
Publikováno v:
Journal of Clinical Oncology. 23:1103-1108
Purpose Patients with newly diagnosed, advanced-stage, follicular grade 1 non-Hodgkin's lymphoma (NHL) are often asymptomatic and can be observed without immediate chemotherapy. The goals of this study were to assess the overall response rate (ORR) t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35473271bd32d42043c77c78a352f886
https://doi.org/10.1200/jco.2005.12.052
https://doi.org/10.1200/jco.2005.12.052
Autor:
Martin S. Tallman, Elisabeth Paietta, George W Schnetzer, William R. Friedenberg, John C. Reed, Isadore Brodsky, Kendrith M Rowland, Jacob M. Rowe, Sandra J. Lee
Publikováno v:
Leukemia Research. 28:813-819
Background & method : The role of multidrug resistance (MDR) was investigated in patients with relapsed chronic lymphocytic leukemia (CLL). PSC-833 was added to modified VAD (a 4-day infusion of vincristine, doxorubicin, with oral dexamethasone, ever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084f4366b53a6969d8bb54d545473650
https://doi.org/10.1016/j.leukres.2003.12.002
https://doi.org/10.1016/j.leukres.2003.12.002
Autor:
Martin S. Tallman, F. Ann Hayes, Jacob M. Rowe, Jane L. Liesveld, Camille N. Abboud, Peter H. Wiernik, John M. Bennett, Adel Z. Makary, William R. Friedenberg, Elisabeth Paietta, Gordon W. Dewald, Donna Neuberg
Publikováno v:
Blood. 103:479-485
The optimal induction for older adults with acute myeloid leukemia (AML) is unknown. Several anthracyclines have been proposed, but the data remain equivocal. Additionally, few prospective trials of priming with hematopoietic growth factors to cycle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b322ba5e54e945de9eea1a2db8c9b3de
https://doi.org/10.1182/blood-2003-05-1686
https://doi.org/10.1182/blood-2003-05-1686
Publikováno v:
The Guthrie Journal. 71:6-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f578c855a58deacc6a8d34b905bd008a
https://doi.org/10.3138/guthrie.71.1.006
https://doi.org/10.3138/guthrie.71.1.006
Publikováno v:
Medical Oncology. 19:125-130
Lymphoma usually presents with painless lymphadenopathy. However, it can also present at an extranodal site. Presentation with skeletal muscle infiltration is relatively uncommon and can be confused with a wide variety of both inflammatory as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c5c175abc41185eb48b2d28c1673fb3
https://doi.org/10.1385/mo:19:2:125
https://doi.org/10.1385/mo:19:2:125
Autor:
Gordon W. Dewald, Jane L. Liesveld, William R. Friedenberg, Elisabeth Paietta, Mary S. Young, Hussain T. Saba, Kenneth B. Miller, Wolfgang Hiddemann, Jacob M. Rowe, John M. Bennett, Robert D. Marsh, F. Ann Hayes, Hillard M. Lazarus
Publikováno v:
American Journal of Hematology. 66:23-27
Rambam Medical Center, Haifa, IsraelA Phase II study of GM-CSF with intermediate-dose cytarabine and mitoxantrone wasconducted in patients with high-risk myelodysplastic syndrome. It was designed to evalu-ate if priming with growth factor could incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2983b1281dd2c92837b8c819c6c60ad
https://doi.org/10.1002/1096-8652(200101)66:1<23::aid-ajh1002>3.0.co
https://doi.org/10.1002/1096-8652(200101)66:1<23::aid-ajh1002>3.0.co
Autor:
Edward A. Stadtmauer, Hillard M. Lazarus, L. Kaminer, Robert M. Golub, T. J. Stinson, William R. Friedenberg, Jacob M. Rowe, Charles L. Bennett, R. W. Marsh, Martin S. Tallman
Publikováno v:
Annals of Oncology. 10:177-182
Summary Purpose Considerable morbidity and mortality and costs occur during induction therapy for acute myeloid leukemia (AML). Colony-stimulating factors (CSFs) can shorten neutropenia, and may lower costs. We performed a cost-minimization analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16c91b2e5fee65b22d427d08ba2e306a
https://doi.org/10.1023/a:1008318930947
https://doi.org/10.1023/a:1008318930947
Autor:
Lee L. Schloesser, James J. Marx, Peter C. Raich, Joseph J. Mazza, Douglas J. Reding, Harry J. Miller, William R. Friedenberg, William G. Hocking, Peter A. Cassileth, Richard J. Mercier
Publikováno v:
American Journal of Clinical Oncology. 18:105-110
Adult patients (> or = 56 years old) with acute myeloid leukemia (AML) received induction therapy consisting of daunorubicin (60 mg/m2), etoposide (80 mg/m2), and cytarabine (200 mg/m2) daily for 5 days by continuous i.v. infusion (120 hours). The in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5095277f1bc7f881f3f53af796d569
https://doi.org/10.1097/00000421-199504000-00003
https://doi.org/10.1097/00000421-199504000-00003
Publikováno v:
The Guthrie Journal. 72:28-30
Primary small cell carcinoma of the bladder is rare. The incidence varies between 0.5-1% of all primary bladder tumors. Fifty percent of small cell carcinomas of the bladder are mixed with other tumors of the bladder. Identifying small cell carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3e35f8e395c22000490c6b5e542b66f
https://doi.org/10.3138/guthrie.72.1.028
https://doi.org/10.3138/guthrie.72.1.028
Publikováno v:
Cancer. 71:2983-2989
Background Thirty-six patients with relapsing or refractory chronic lymphocytic leukemia were entered into a Phase II study of the Eastern Cooperative Oncology Group. Methods A modified VAD regimen was given: a 96-hour infusion of 1.6 mg vincristine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71d50351e46d352e03d468bf9bf42ef0
https://doi.org/10.1002/1097-0142(19930515)71:10<2983::aid-cncr2820711016>3.0.co
https://doi.org/10.1002/1097-0142(19930515)71:10<2983::aid-cncr2820711016>3.0.co